Michael Luebbert
Impact in
-
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders
Papers in
-
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 2
- Genetics 3
- Chronic Lymphocytic Leukemia Research 2
- Genomic variations and chromosomal abnormalities 2
- Co-authors
- J. Thiele (1 shared paper)Volker Diehl (1 shared paper)Annette Schmitt‐Graeff (1 shared paper)H. M. Kvasnicka (1 shared paper)J. W. Vardiman (1 shared paper)Christa Fonatsch (3 shared papers)Ulrich Germing (4 shared papers)Augustin Ferrant (1 shared paper)
- Journals
- Blood (7 papers)Annals of Hematology (1 paper)Research Portal (King's College London) (1 paper)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Michael Luebbert
8 papers receiving 33 citations
Peers
Comparison fields: 5 of 11
- Hematology 29
- Genetics 16
- Emergency Medicine 3
- Public Health, Environmental and Occupational Health 9
- Pathology and Forensic Medicine 5
Countries citing papers authored by Michael Luebbert
This map shows the geographic impact of Michael Luebbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Luebbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Luebbert more than expected).
Fields of papers citing papers by Michael Luebbert
This network shows the impact of papers produced by Michael Luebbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Luebbert. The network helps show where Michael Luebbert may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Luebbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 12 | |
| 2 | 2006 | 7 | |
| 3 | 2006 | 6 | |
| 4 | DNA demethylating therapy in MDS: The experience with 5-AZA-2 '-deoxycytidine (decitabine). | 1999 | 4 |
| 5 | 2007 | 1 | |
| 6 | 2005 | 1 | |
| 7 | 2008 | 1 | |
| 8 | Valuation of transfusion-free living in MDS: results of health utility interviews with patients | 2009 | 1 |
| 9 | 2011 | 0 |
About Michael Luebbert
Michael Luebbert is a scholar working on Hematology, Genetics, Molecular Biology, Pathology and Forensic Medicine and Genetics, having authored 9 papers that have together received 33 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Histone Deacetylase Inhibitors Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Hematological disorders and diagnostics (2 papers), Epigenetics and DNA Methylation (2 papers), Genomic variations and chromosomal abnormalities (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Hematology (29 citations), Genetics (16 citations), Emergency Medicine (3 citations), Public Health, Environmental and Occupational Health (9 citations) and Pathology and Forensic Medicine (5 citations). Michael Luebbert has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include J. Thiele, Volker Diehl, Annette Schmitt‐Graeff, H. M. Kvasnicka, J. W. Vardiman, Christa Fonatsch, Ulrich Germing, Augustin Ferrant, Harm R. Haak and P. Wijermans. Their work appears in journals such as Blood, Annals of Hematology and Research Portal (King's College London).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.